FMC Odyssey Dialysis is a medicare approved dialysis facility center in Madison, Alabama and it has 15 dialysis stations. It is located in Madison county at 40 Hughes Road, Madison, AL, 35758. You can reach out to the office of FMC Odyssey Dialysis at (256) 772-4435. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Odyssey Dialysis has the following ownership type - Profit. It was first certified by medicare in May, 1999. The medicare id for this facility is 012593 and it accepts patients under medicare ESRD program.
| Name | FMC Odyssey Dialysis |
|---|---|
| Location | 40 Hughes Road, Madison, Alabama |
| No. of Dialysis Stations | 15 |
| Medicare ID | 012593 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 40 Hughes Road, Madison, Alabama, 35758 | |
| (256) 772-4435 | |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
| NPI Number | 1245342054 |
| Organization Name | Fmc Dialysis Services Odyssey |
| Doing Business As | Bio-medical Applications Of Alabama, Inc. |
| Address | 40 Hughes Rd Madison, Alabama, 35758 |
| Phone Number | (256) 772-4435 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 29 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 10 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 59 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 492 |
| Percentage of adult patients getting regular hemodialysis at the center | 92 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Odyssey Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 63 |
| Hypercalcemia patient months | 526 |
| Patients with Serumphosphor | 68 |
| Patients with Serumphosphor less than 3.5 mg/dL | 5 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 30 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 72 |
| Patient months included in arterial venous fistula and catheter summaries | 433 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 68 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 52 |
| Hospitalization Rate in facility | 127.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 251.8 |
| Hospitalization Rate: Lower Confidence Limit | 67.9 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC Odyssey Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 30.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 46.1 |
| Readmission Rate: Lower Confidence Limit | 17.9 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC Odyssey Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .3 (As Expected) |
| SIR: Upper Confidence Limit | 1.46 |
| SIR: Lower Confidence Limit | .02 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC Odyssey Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 44 |
| Transfusion Rate in facility | 69.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 160.3 |
| Transfusion Rate: Lower Confidence Limit | 33.6 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC Odyssey Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 249 |
| Mortality Rate in facility | 18.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 25.3 |
| Mortality Rate: Lower Confidence Limit | 12.7 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago
Fresenius Medical Care West Madison, Llc Location: 29569 Huntsville Browns Ferry Rd, Madison, Alabama, 35756 Phone: (256) 233-5757 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Better education and training for management of sleep problems is needed, including a clear primary care pathway to treatment, suggests the experience of patients and clinicians in the UK.
Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology.
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
The Wall Street Journal reports on efforts to make the language used in doctors' offices easier for patients to understand.
› Verified 4 days ago